TCM
MDGL icon

Tao Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Tao Capital Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3M Hold
21,000
– – 0.58% 5
2026
Q1 		$11M Hold
21,000
– – 9.25% 4
2025
Q4 		$12.2M Sell
21,000
-20,000
-49% -$10.2M 10.53% 4
2025
Q3 		$18.8M Sell
41,000
-71,785
-64% -$26.8M 14.22% 4
2025
Q2 		$34.1M Hold
112,785
– – 25.03% 1
2025
Q1 		$37.4M Sell
112,785
-17,744
-14% -$5.83M 32.17% 1
2024
Q4 		$40.3M Hold
130,529
– – 28.11% 1
2024
Q3 		$27.7M Hold
130,529
– – 25.09% 2
2024
Q2 		$36.6M Hold
130,529
– – 29.98% 2
2024
Q1 		$34.9M Hold
130,529
– – 33.02% 1
2023
Q4 		$30.2M Buy
130,529
+52,872
+68% +$9.25M 27.63% 2
2023
Q3 		$11.3M Hold
77,657
– – 8.78% 4
2023
Q2 		$17.9M Hold
77,657
– – 13.14% 3
2023
Q1 		$18.8M Hold
77,657
– – 14.97% 2
2022
Q4 		$22.5M Hold
77,657
– – 16.95% 2
2022
Q3 		$5.05M Hold
77,657
– – 3.31% 9
2022
Q2 		$5.56M Hold
77,657
– – 3.85% 8
2022
Q1 		$7.62M Hold
77,657
– – 2.78% 9
2021
Q4 		$6.58M Buy
77,657
+26,261
+51% +$2.16M 2.01% 10
2021
Q3 		$4.1M Hold
51,396
– – 1.09% 10
2021
Q2 		$5.01M Hold
51,396
– – 1.15% 9
2021
Q1 		$6.01M Hold
51,396
– – 1.74% 6
2020
Q4 		$5.71M Hold
51,396
– – 1.41% 5
2020
Q3 		$6.1M Buy
+51,396
New +$5.58M 1.97% 4

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Tao Capital Management's MDGL Position: Q2 2026 in Review

Tao Capital Management held its Madrigal Pharmaceuticals (MDGL) position steady in Q2 2026 at 21,000 shares worth $11.3M. The position accounts for 0.58% of the portfolio, ranked #5.

Tao Capital Management first reported a position in MDGL in Q3 2020 and has held it in 24 quarters since. The position peaked at $40.3M in Q4 2024. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Tao Capital Management held 21,000 shares of Madrigal Pharmaceuticals worth $11.3M as of Q2 2026.
  • Tao Capital Management left its Madrigal Pharmaceuticals share count unchanged in Q2 2026.
  • Madrigal Pharmaceuticals made up 0.58% of Tao Capital Management's portfolio in Q2 2026, its #5 holding.
  • Tao Capital Management first reported a position in Madrigal Pharmaceuticals in Q3 2020 and has held it in 24 quarters since.
  • Tao Capital Management's Madrigal Pharmaceuticals position peaked at $40.3M in Q4 2024.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Tao Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.